Acumen Pharmaceuticals (ABOS) Interest Coverage Ratio (2021 - 2026)

Acumen Pharmaceuticals has disclosed Interest Coverage Ratio across 5 years of filings, most recently posting 29.76 for Q2 2026.

• In Q2 2026, Interest Coverage Ratio rose 25.44% year-over-year to 29.76; the TTM figure through Jun 2026 stood at 24.41 (up 29.92% YoY), while the FY2025 annual figure was 29.32, down 4.6% from the prior year.
• Interest Coverage Ratio came in at 29.76 for Q2 2026 at Acumen Pharmaceuticals, down from 19.78 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 17.77 in Q1 2024 to a low of 39.91 in Q2 2025.
• Average Interest Coverage Ratio over 4 years is 28.24, with a median of 29.69 recorded in 2025.
• The largest YoY upside for Interest Coverage Ratio was 39.29% in 2025 against a maximum downside of 67.03% in 2025.
• Over 4 years, Interest Coverage Ratio stood at 31.82 in 2023, then fell by 20.01% to 38.18 in 2024, then surged by 39.29% to 23.18 in 2025, then retreated by 28.37% to 29.76 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 29.76 in Q2 2026, 19.78 in Q1 2026, and 23.18 in Q4 2025.